Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| 1 |
Invesco S&P 500 Revenue ETF
RWL
|
$658M |
| 2 |
Tesla
TSLA
|
$573M |
| 3 |
Bank of America
BAC
|
$480M |
| 4 |
Amazon
AMZN
|
$448M |
| 5 |
Canadian Pacific Kansas City
CP
|
$445M |
Top Sells
| 1 |
Invesco S&P 500 Pure Value ETF
RPV
|
$493M |
| 2 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$395M |
| 3 |
Eli Lilly
LLY
|
$364M |
| 4 |
CME Group
CME
|
$316M |
| 5 |
T-Mobile US
TMUS
|
$310M |
Sector Composition
| 1 | Technology | 23.42% |
| 2 | Financials | 13.31% |
| 3 | Industrials | 11.28% |
| 4 | Healthcare | 10.55% |
| 5 | Consumer Discretionary | 10.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3576
Liberty Latin America Class A
LILA
$1.6B
| $76.2K | ﹤0.01% |
12,038
-125,545
| -91% | -$795K |
|
3577
scPharmaceuticals
SCPH
$299M
| $75.5K | ﹤0.01% |
28,702
+1,088
| +4% | +$2.86K |
|
3578
ThredUp
TDUP
$1.43B
| $72.3K | ﹤0.01% |
30,019
-360
| -1% | -$868 |
|
3579
Pulmonx
LUNG
$70.9M
| $72K | ﹤0.01% |
10,698
-816
| -7% | -$5.49K |
|
3580
RAPT Therapeutics
RAPT
$214M
| $71.9K | ﹤0.01% |
7,363
+5,924
| +412% | +$57.8K |
|
3581
Acrivon Therapeutics
ACRV
$41.8M
| $71.7K | ﹤0.01% |
+35,315
| New | +$71.7K |
|
3582
Kaltura
KLTR
$226M
| $71.7K | ﹤0.01% |
38,131
-2,015
| -5% | -$3.79K |
|
3583
Black Diamond Therapeutics
BDTX
$167M
| $71.3K | ﹤0.01% |
45,989
+27,777
| +153% | +$43.1K |
|
|
SEPN
3584
Septerna, Inc. Common Stock
SEPN
$643M
| $70.6K | ﹤0.01% |
12,202
+48
| +0.4% | +$278 |
|
3585
Compass Therapeutics
CMPX
$590M
| $70.6K | ﹤0.01% |
37,157
-2,326
| -6% | -$4.42K |
|
3586
Nano X Imaging
NNOX
$236M
| $69.3K | ﹤0.01% |
13,876
-871
| -6% | -$4.35K |
|
3587
LINKBANCORP
LNKB
$270M
| $68.5K | ﹤0.01% |
10,098
-370
| -4% | -$2.51K |
|
3588
Alto Neuroscience
ANRO
$99.4M
| $67K | ﹤0.01% |
+31,031
| New | +$67K |
|
|
HSHP
3589
Himalaya Shipping
HSHP
$374M
| $66.4K | ﹤0.01% |
12,119
-619
| -5% | -$3.39K |
|
3590
Invivyd
IVVD
$239M
| $66K | ﹤0.01% |
108,999
+71,485
| +191% | +$43.3K |
|
3591
Precigen
PGEN
$1.3B
| $65.3K | ﹤0.01% |
43,806
-3,501
| -7% | -$5.22K |
|
|
NNDM
3592
Nano Dimension
NNDM
$293M
| $63.4K | ﹤0.01% |
+39,846
| New | +$63.4K |
|
|
AKYA
3593
DELISTED
Akoya BioSciences
AKYA
| $62.7K | ﹤0.01% |
+45,141
| New | +$62.7K |
|
3594
SuRo Capital
SSSS
$207M
| $62.3K | ﹤0.01% |
+12,526
| New | +$62.3K |
|
3595
Vivid Seats
SEAT
$103M
| $62.2K | ﹤0.01% |
1,052
-94
| -8% | -$5.56K |
|
3596
Sutro Biopharma
STRO
$89.9M
| $59.9K | ﹤0.01% |
92,139
+53,390
| +138% | +$34.7K |
|
3597
Cardiff Oncology
CRDF
$144M
| $59.8K | ﹤0.01% |
19,046
+161
| +0.9% | +$506 |
|
|
VXRT
3598
DELISTED
Vaxart
VXRT
| $59.6K | ﹤0.01% |
146,366
+70,568
| +93% | +$28.7K |
|
3599
Candel Therapeutics
CADL
$274M
| $58.8K | ﹤0.01% |
+10,413
| New | +$58.8K |
|
3600
HF Foods Group
HFFG
$170M
| $57.4K | ﹤0.01% |
11,719
-630
| -5% | -$3.09K |
|